rs10039254

This is a intron variant variant in the ADAMTS2 gene.

Research that mentions this SNP (1)

Genome‐wide association scan of the time to onset of attention deficit hyperactivity disorder
AssociationN=930Jessica Lasky‐Su et al.(2008)· American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

Genome-wide association scan of 930 ADHD proband-parent trios genotyped on 429,981 autosomal SNPs to identify associations with age of ADHD symptom onset. No genome-wide significant associations were found (lowest p-value 1.02×10⁻⁷ at rs9451437 on chromosome 6), but 14 SNPs showed p-values <10⁻⁵, with the most promising findings in SLC9A9 (6 distinct regions with nominal associations including rs130575, rs552655, rs13353224, rs708188, rs13057533).

Traits studied:Age at onset of ADHDAttention Deficit Hyperactivity Disorder (ADHD)Hyperactivity-impulsivity symptomsInattention symptoms

About ADAMTS2

This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature procollagen N-proteinase. This proteinase excises the N-propeptide of the fibrillar procollagens types I-III and type V. Mutations in this gene cause Ehlers-Danlos syndrome type VIIC, a recessively inherited connective-tissue disorder. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]

View all ADAMTS2 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…